Manufacturing

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Articles

Manufacturers are taking the first steps toward process intensification. 

Continuous Processing for Viral Vectors

MilliporeSigma’s ZooMAb antibodies have been recognized for their low environmental impact by My Green Lab.

MilliporeSigma’s ZooMAb Antibodies Earn ACT Label from My Green Lab

Feliza Mirasol is the science editor for 

The growing demand for antibody and other bio-therapeutics will require long-term scale-up solutions.

Large-Scale Single-Use Bioreactors Can Maximize Long-Term Scale Up

Grant Playter is the Assistant Editor for 

The past year of downstream processing has brought innovations in pH sensitive antibody purification, single-use fermentation separators, and more.

What’s New in Downstream Processing?

AstraZeneca’s antibody combination has been authorized for use in Great Britain to prevent COVID-19 in high-risk populations and people for whom vaccination may not be effective.

AstraZeneca’s Antibody Combination Authorized for Use in Great Britain for Prevention of COVID-19

Adagene has announced SAFEbody multi-target collaboration with Sanofi for novel masked immuno-oncology antibody candidates.

Adagene Announces Collaboration with Sanofi for Novel Masked Immuno-Oncology Antibody Candidates

The use of bioengineering offers practical tools for the evolution of host cells.

Outlining Cell Lines’ Future with Engineering Approaches

Anurag S. Rathore is a professor in the Department of Chemical Engineering at the Indian Institute of Technology Delhi and a member of 

l's Editorial Advisory Board, Tel. +91.9650770650, asrathore@biotechcmz.com.

Rozaleen Dash is a post-doctoral fellow in the Department of Chemical Engineering at the Indian Institute of Technology (Delhi). 

The authors review some of the monoclonal antibody candidates that reached Phase III clinical trials but were discontinued at later stages.

Late-Stage Failures of Monoclonal Antibodies

Piramal Pharma Solutions plans to construct a multipurpose ADC manufacturing and aseptic fill/finish facility in Grangemouth, Scotland, and to upgrades its existing API manufacturing facility in Morpeth, England.

Piramal Pharma Solutions Expands and Upgrades UK Manufacturing Facilities

The growing use of automation and digitalization technologies push cell culture bioprocessing forward.

Manufacturing, Monoclonal Antibodies